Drugs / MPL
last change Jan 2007 re-read 3 minutes ago

MPL

Developed for
hypersensitivity reaction disease
Investigated by
Allergy Therapeutics

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00241410 Dec 2005 → Jan 2007 hypersensitivity reaction disease Allergy Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MPL ClinicalTrials.gov intervention name — accepted as the source's own label NCT00241410 ↗